M2 Pharma - Therapy Areas - Cardiovascular

KKR to purchase controlling stake in J.B. Chemicals & Pharmaceuticals of India

3 July 2020 - Investment firm KKR & Co Inc (NYSE:KKR) reported on Thursday that it has entered into a definitive agreement to purchase a controlling stake in J.B. Chemicals & Pharmaceuticals L...

Cancer Prevention Pharmaceuticals Submits New Drug Application to the FDA for CPP-1X/sul for Treatment of Familial Adenomatous Polyposis

2 July 2020 - - US-based biotechnology company Cancer Prevention Pharmaceuticals, Inc has submitted a New Drug Application to the US Food and Drug Administration seeking accelerated approval for CPP-1...

PolyPid begins first phase three clinical trial of D-PLEX100

2 July 2020 - PolyPid Ltd (Nasdaq: PYPD), an Israel-based biopharmaceutical company, has enrolled and randomised the first patient in the SHIELD I (Surgical site Hospital acquired Infection prEvention...

Moderna and Catalent Team for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine Candidate

25 June 2020 - - US-based biotechnology company Moderna, Inc. (NASDAQ: MRNA) and US-based delivery technologies, development, and manufacturing solutions provider Catalent, Inc. (NYSE: CTLT) have forg...

Frontier Scientific Teams with Renibus Therapuetics On COVID-19 Therapeutic Investigational Drug Development

24 June 2020 - - US-based Frontier Scientific, a specialist in porphyrin chemistry and chemical building blocks for drug discovery and material science research, is collaborating with Renibus Therapue...

Ablacon establishes Scientific Advisory Board

24 June 2020 - Ablacon, Inc, a company supported by Ajax Health, has established a Scientific Advisory Board that will include four leaders in the field of electrophysiology to guide the company in it...